237
Views
10
CrossRef citations to date
0
Altmetric
Review

Non-invasive ventilation in exacerbations of COPD

&
Pages 471-476 | Published online: 20 Oct 2022

Abstract

Randomized controlled trials have confirmed the evidence and helped to define when and where non invasive mechanical ventilation (NIV) should be the first line treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Noninvasive ventilation has its best indication in moderate-to-severe respiratory acidosis in patients with AECOPD. For this indication, studies conducted in ICU, in wards and in accident and emergency departments confirmed its effectiveness in preventing endotracheal intubation and reducing mortality. The skill of the health care team promotes proper NIV utilization and improves the patient outcome. Patients with severe acidosis or with altered levels of consciousness due to hypercapnic acute respiratory failure are exposed to high risk of NIV failure. In these patients a NIV trial may be attempted in closely monitored clinical settings where prompt endotracheal intubation may be assured.

COPD exacerbations and acute respiratory failure

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are periods of acute worsening which greatly affect the health status of those patients with an increase in hospital admission and mortality (CitationDonaldson et al 2006). Estimates of in-patient mortality range from 4% to 30%, but patients admitted due to acute respiratory failure (ARF) experience a higher rate, in particular elderly patients with co-morbidities (up to 50%) and those requiring intensive care unit (ICU) admission (11%–26%) (CitationAmerican Thoracic Society Statement 1995; CitationSeneff et al 1995; CitationConnors et al 1996; CitationBach et al 2001; CitationPatil et al 2003).

Many causes may potentially be involved in determining ARF during AECOPD, such as bronchial infections, bronchospasm, left ventricular failure, pneumonia, pneumothorax and thromboembolism (Derenne et al 1996).

The ARF in the setting of an AECOPD is characterized by the worsening of hypoxemia and a variable degree of carbon dioxide retention and acidemia.

The capacity of the patient to maintain acceptable indices of gas exchange during an AECOPD or the development of ARF depends both from the severity of the precipitating cause and from the degree of physiological dysfunction during the stable state and the subsequent physiological reserve.

Worsening in ventilation to perfusion ratio (V/Q) mismatching is probably the leading mechanism in the occurrence of the hypoxemia by the enlargement of physiological dead space and the rise of wasted ventilation (CitationCalverley 2003).

The increase in airway resistance and the need of a higher minute ventilation may result in expiratory flow limitation, dynamic hyperinflation and related intrinsic Positive end expiratory pressure (PEEPi) with subsequent increased inspiratory threshold load and dysfunction of the respiratory muscles, which may lead to their fatigue (CitationO’Donnell and Parker 2006).

A rapid shallow breathing pattern may ensue in attempting to maintain adequate alveolar ventilation when these additional resistive, elastic and inspiratory threshold loads are imposed on weakened respiratory muscles, but despite increased stimulation of the respiratory centers and large negative intrathoracic pressure swings, carbon dioxide retention and acidemia may occur.

Dyspnea, right ventricular failure, and encephalopathy characterize severe AECOPD complicated by ARF (CitationRossi et al 1995; CitationSimilowski et al 1996; CitationAmbrosino et al 1997). Arterial pH reflects the acute worsening of the alveolar ventilation and, regardless of the chronic level of arterial CO2 tension (PaCO2), it represents the best marker of the ARF severity (CitationPlant and Elliott 2003).

Effectiveness and indications of NIV

The optimum pharmacological treatment of the exacerbations of COPD is based on the so called “ABC approach”, an acronym that reflects the three classes of drugs (antibiotics, bronchodilators, corticosteroids) commonly used.

Controlled oxygen therapy and ventilatory support (invasive and non-invasive) are options able to improve symptoms and survival of the ARF patients by preventing tissue hypoxia and controlling acidosis and hypercapnia (CitationPlant and Elliott 2003).

While medical treatment works to maximize lung function and reverse the precipitating cause of the exacerbations, ventilatory support can lower the level of respiratory muscles load, thus reducing dyspnea and respiratory rate, and improving arterial oxygenation, PaCO2, and pH (CitationRodrìguez-Roisin 2006; CitationBrochard et al 1990).

Some complications of invasive ventilation are related to the intubation or tracheotomy procedure; or to ventilation such as ventilator-associated pneumonia (VAP) and other nosocomial infections. Non-invasive methods of mechanical ventilation (NIV) may avoid most of the complications related to the invasive ventilation, ensuring at the same time a similar degree of efficacy (CitationPingleton 1994; CitationGirou et al 2000).

Both negative and positive pressure ventilation have been used to this purpose (CitationAmbrosino and Corrado 2001); in this article we will focus only on non-invasive positive pressure ventilation delivered by face or nasal masks.

The international consensus conference on NIV for acute respiratory failure stated that “the addition of NIV to standard medical treatment of patients with ARF may prevent the need for intubation and reduce the rate of complications and mortality in patients with hypercapnic respiratory failure” (CitationEvans 2001). The reduction of complications related to the endotracheal intubation and to the weaning from the invasive mechanical ventilation is the main factor affecting mortality (CitationBrochard et al 1995; CitationKramer et al 1995; CitationKeenan et al 2000). Moreover, NIV can be applied earlier than intubation in the course of ventilatory failure and can be administered outside of the ICU (CitationEvans 2001; CitationMehta and Hill 2001).

Several prospective, randomized, controlled studies (CitationBott et al 1993; CitationBrochard et al 1995; CitationKramer et al 1995; CitationBarbè et al 1996; CitationCelikel et al 1998; CitationPlant et al 2000a; CitationConti et al 2002; CitationSquadrone et al 2004) included in a recent meta-analysis (CitationLightlower et al 2003) and summarized in a clinical commentary (CitationNava et al 2006) confirmed the clinical efficacy of NIV in the treatment of the ARF during AECOPD: compared to standard medical therapy alone the application of NIV improves survival, reduces the need for endotracheal intubation and the rate of complications, and shortens length of stay in hospital and in ICU.

In patients with mild to moderate ARF, characterized by pH levels between 7.25 and 7.35, NIV was administered for few hours per day (<12h/day) with low failure rates ranging from 15% to 20% (CitationElliott 2002; CitationLightowler et al 2003).

In these patients, NIV is indicated to prevent endotracheal intubation (CitationNava et al 2006).

In more severely ill patients (pH < 7.25), the rate of NIV failure was inversely related to the severity of respiratory acidosis, rising up to 52%–62% (CitationConti et al 2002; CitationSquadrone et al 2004). The use of NIV in alternative to the invasive ventilation does not affect the mortality rate and the duration of ventilatory support, but the patients treated with NIV are subjected to a lower rate of complications (VAP, difficult weaning). In these patients, although exposed to high risk of failure, a NIV trial may be justified, if intubation is not strictly required because the need of protecting the airways, loss of consciousness or gasping (CitationConti et al 2002; CitationSquadrone et al 2004; CitationNava et al 2006).

In patients with “mild” exacerbations, not complicated by respiratory acidosis, the use of NIV was investigated by few studies, including patients in large majority with pH > 7.35, who failed in demonstrate a better effectiveness of NIV than standard medical therapy in preventing the occurrence of the ARF. No significant improvement in mortality and hospitalization duration was found, and the tolerance of the patients to the NIV was less than 50% (CitationBardi et al 2000; CitationKeenan et al 2005).

NIV as a weaning technique in AECOPD

In selected invasively ventilated patients with AECOPD who had previously failed a weaning trial, NIV may be safely and successfully used after a few days of invasive ventilation in order to shorten weaning time, reduce ventilator-associated complications, and improve survival (CitationNava et al 1998; CitationGirault et al 1999; CitationFerrer et al 2003). It has been demonstrated NIV is as able as invasive ventilation to unload respiratory muscles. (CitationVitacca et al 2001).

Determinants for success or failure

NIV failure occurs more frequently in the first hours of ventilation, and was reported to be predicted by the following clinical factors: severe acidosis, high severity score, severe impairment of consciousness, presence of co-morbidities and lack of improvement of arterial blood gases after 1–2 hours of initial ventilation (CitationAmbrosino et al 1995; CitationElliott 2002; CitationNava and Ceriana 2004; CitationConfalonieri et al 2005). Nevertheless COPD patients with severe ARF treated with NIV, particularly those with more severe functional impairment during the stable state, may have a late worsening (after > 48hrs), often requiring endotracheal intubation, despite an initial brief improvement (Moretti et al 2000).

Community acquired pneumonia (CAP) was related to a high NIV failure rate in patients with hypoxemic ARF (Antonelli et al 2001; CitationJolliet et al 2001). Concerning the efficiency of NIV in COPD patients with severe CAP the available data are not conclusive. The only one randomized study including COPD patients with hypercapnic ARF and pneumonia (Confalonieri et al 2001) showed that NIV may reduce the rate of intubation and complications in comparison with medical therapy. The same advantages were not achieved when NIV was compared to conventional mechanical ventilation (CitationHonrubia et al 2005). Moreover, non-controlled studies reported conflicting results on the outcome of NIV in patients with COPD and pneumonia (CitationMeduri et al 1996; CitationAmbrosino et al 1997; CitationConfalonieri et al 2005; CitationPhua et al 2005).

When acute exacerbation of COPD with hypercapnic ARF is due to cardiogenic edema the treatment with bi-level NIV has shown to reduce intubation rate (Masip et al 2000; CitationNava et al 2003).

Contraindications to NIV

Most of the contraindications to NIV as listed in are derived from exclusion criteria for the controlled trials (CitationBrochard et al 1995). Therefore it is more correct to state that NIV is not proven in these circumstances rather than it is contraindicated (CitationElliott 2004).

Table 1 Absolute contraindications for NIV

Particularly, severe encephalopathy with glasgow coma scale (GCS) <10 was considered a contraindication to NIV treatment based on the concern that a depressed sensorium would predispose the patient to aspiration (CitationEvans 2001). More recently some experiences of NIV treatment of patients with altered levels of consciousness, due to hypercapnic ARF, were reported. These observations need to be confirmed by randomized controlled trials but suggest the feasibility of NIV in such patients, with acceptable rates of failure and low rates of aspiration complications (CitationDiaz et al 2005; CitationScala et al 2005).

The use of NIV in different clinical settings (where to use NIV?)

Several randomized controlled studies support the effectiveness of NIV in the ICU, in the ward and in the accident and emergency departments. Most of these trials included patients with an AECOPD and a mild-to-moderate respiratory acidosis (CitationPlant and Elliott 2003).

Despite the evidence supporting its use, the NIV availability and its use varies widely among medical centers and in different countries. In 20%–52% of the hospitals in European countries NIV was reported unavailable and its utilization rate varied from 15% to 80% in COPD patients who need ventilatory support (CitationDoherty and Greenstone 1998; CitationCarlucci et al 2001; CitationGirault et al 2003). In the United States NIV was recently reported to be more available, but frequently (42% of the hospitals) resulted underutilized due to inadequate equipment and lack of physician knowledge and training (CitationBurns et al 2005; Maheshvari et al 2006).

Cost-effectiveness of NIV

By pooling four NIV studies conducted in the ICU the risk of intubation was reduced from 63% to 21% and the mortality from 25% to 9%; the numbers needed to treat (NNT) were 2.4 to prevent one intubation and 6.3 to prevent one death; in the largest ward trial the probability to meet criteria for endotracheal intubation was reduced from 27% to 15%, and the real intubation rate from 11% to 6%; the NNT was 8.3 to prevent criteria for intubation and 20 to prevent real intubation (CitationPlant and Elliott 2003).

Non invasive ventilation has been shown to be cost effective in ICU setting, resulting in an improved clinical outcome and reduced costs (CitationKeenan 2000); also the use of NIV in ward setting reduces mortality, the demand for intensive care, and lowers the costs (CitationPlant et al 2003).

Studies specifically addressed to the workload for the personnel working with NIV found a different distribution of this workload compared to a more traditional approach towards patients with ARF (CitationKramer et al 1995; CitationNava et al 1997; CitationPlant et al 2000a). The first 6 to 8 hours are usually associated with a high level of workload, reflecting the need for the personnel to remain at the bedside (CitationPlant et al 2000a). Nevertheless the financial and human resources implications of NIV compared to invasive mechanical ventilation are still unclear. There is evidence that some COPD patients with less severe ARF without failure of any other organ may be successfully treated with lower costs in the respiratory intermediate intensive care unit (RIICU) and even in the ward than in the ICU (CitationPlant and Elliott 2003; CitationBertolini et al 2005).

Devices (ventilators and interfaces)

In theory NIV could be delivered with similar modalities as through an endotracheal tube or a tracheostomy cannula. In reality the circumstances of ventilation and the equipment available are different (CitationLellouche et al 2002). NIV is usually delivered in assisted ventilation modality but no differences in success rate were found when applied in controlled ventilation modality (Vitacca et al 2003).

The presence of gas leaks is a near-constant feature of NIV and may affect triggering of the ventilator, delivered FiO2, and air humidification. Differences were found depending on the ventilator used (“home” vs “ICU” ventilators). While home ventilators could adequately compensate large gas leaks, ICU ventilators are not able to cope with large leaks and needs to titrate trigger sensitivity to avoid auto-triggering and asynchrony between the patient and the ventilator (CitationNava et al 1997; CitationRichard et al 2002; CitationTassaux et al 2002; CitationMiyoshi et al 2005).

The choice of the interface is one of the crucial issues affecting NIV outcome; although face mask is the standard interface to deliver NIV in patients with ARF, poor mask tolerance, skin lesions, leaks are reported among factors causing NIV failure and intubation requirement (CitationMehta 2001). No difference in success rate but a better compliance with oro-nasal than with nasal mask was reported (CitationKwok et al 2003).

More recently a helmet mask has been introduced to deliver NIV reducing discomfort, pressure necrosis of the skin, eyes irritation and gastric distension

Some mechanical characteristics of the helmets, primarily its large volume and its highly compliant soft collar compared with face mask, might however impair patient-ventilator interaction. In normal volunteers, when NIV was delivered with an helmet an increase in delay time and in wasted inspiratory efforts were observed compared to a face mask; when a resistive load was imposed, the inspiratory effort and patient-ventilator asynchrony increased, and CO2 clearance worsened (CitationCosta et al 2005; CitationRacca et al 2005; CitationMoerer et al 2006).

Regardless to the interface used, in order to reduce the risk of nosocomial transmission of respiratory tract infections and potential risks for the health care workers, careful fitting on the face and the addition of a viral-bacterial filter to the NIV system between the mask and the exhalation port should be recommended (CitationHui et al 2006).

What’s new?

Proportional assist ventilation (PAV), a mode of partial ventilatory assistance endowed with characteristics of proportionality and adaptability to the intensity and timing of spontaneous ventilatory patterns, when delivered by mask, was effective in improving arterial blood gases and reducing WOB in severe AECOPD (CitationVitacca et al 2000), but was not clinically superior to mask pressure support in a multicentric study (CitationGay et al 2001; CitationAmbrosino and Rossi 2002).

The use of a helium-oxygen mixture seems very promising during NIV in AECOPD to further reduce dyspnea and WOB and in reducing hospital length of stay, but not in improving the success rate (CitationJaber et al 2000; CitationJolliet et al 2003). The use of heliox is difficult because the lack of availability of an approved heliox-delivery system, and appropriately designed randomized controlled trials are needed to define the role for heliox combined with NIV in COPD patients (CitationHess 2006).

Conclusion

Randomized controlled trials have confirmed the evidence and helped to define when and where NIV should be the first line treatment of AECOPD. This does not mean that NIV is a panacea for AECOPD. Furthermore great attention must be devoted to risk of NIV failure, being always able to intervene with appropriate endotracheal intubation.

Abbreviations

AECOPD=

acute exacerbation of chronic obstructive pulmonary disease

ARF=

acute respiratory failure

COPD=

chronic obstructive pulmonary disease

CPAP=

continuous positive airway pressure

GCS=

glasgow coma scale

ICU=

intensive care unit

NIV=

non-invasive mechanical ventilation

NNT=

numbers needed to treat

PEEPi=

intrinsic positive end expiratory pressure

PaCO2=

arterial partial pressure of CO2

PAV=

proportional assist ventilation

VAP=

ventilator-associated pneumonia

V/Q=

ventilation to perfusion ratio

WOB=

work of breathing

References

  • AmbrosinoNFoglioKRubiniF1995Non-invasive mechanical ventilation in acute respiratory failure due to chronic airways disease: correlates for successThorax5075577570410
  • AmbrosinoNGanassiniARossiA1997Advanced chronic obstructive pulmonary diseaseMonaldi Arch Chest Dis5257489550870
  • AmbrosinoNCorradoA2001Obstructive pulmonary disease with acute respiratory failureMuirJFSimondsAKAmbrosinoNNoninvasive mechanical ventilation. Eur Respir Mon161132
  • AmbrosinoNRossiA2002Proportional assist ventilation (PAV): a significant advance or a futile struggle between logic and practice?Thorax57272611867835
  • American Thoracic Society Statement1995Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med152S771207582322
  • BachPBBrownCGelfandSE2001Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidenceAnn Intern Med1346002011281745
  • BarbèFTogoresBRubiM1996Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary diseaseEur Respir J9124058804944
  • BarberaJARocaJFerrerA1997Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary diseaseEur Respir J101285919192930
  • BardiGPieroteloRDesideriM2000Nasal ventilation in COPD exacerbations: early and late results of a prospective, controlled studyEur Respir J159810410678628
  • BertoliniGConfalonieriMRossiC2005Costs of COPD. Differences between intensive care unit and respiratory intermediate intensive care unitRespir Med9989490015939252
  • BottJCarrollMPConwayJH1993Randomized controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways diseaseLancet341155578099639
  • BrochardLManceboJWysockiM1995Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary diseaseN Engl J Med333817227651472
  • BrochardLIsabeyDPiquetJ1990Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face maskN Engl J Med3231523302122253
  • BurnsKSinuffTAdhikariN2005Bilevel noninvasive positive pressure ventilation for acute respiratory failure: Survey of Ontario practiceCrit Care Med3314778316003051
  • CalverleyPMA2003Respiratory failure in chronic obstructive pulmonary diseaseEur Respir J222630s
  • CarlucciARichardJ-CWysockiM2001Noninvasive versus conventional mechanical ventilation. An epidemiological surveyAm J Respir Crit Care Med1638748011282759
  • CarlucciADelmastroMRubiniF2003Changes in the practice of non-invasive ventilation in treating COPD patients over 8 yearsIntensive Care Med2951925
  • CelikelTSungurMCeyhanB1998Comparison of non-invasive positive pressure ventilation in acute respiratory failureChest1141636429872200
  • ConfalonieriMPotenaACarboneG1999Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilationAm J Respir Crit Care Med16015859110556125
  • ConfalonieriMGarutiMCattaruzzaMS2005A chart of failure risk for noninvasive ventilation in patients with COPD exacerbationsEur Respir J253485515684302
  • ConnorsAFDawsonNVThomasCfor the SUPPORT investigators1996Outcomes following acute exacerbations of chronic bronchitisAm J Respir Crit Care Med15495867
  • ContiMAntonelliMNavalesiP2002Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trialIntensive Care Med281701712447511
  • CostaRNavalesiPAntonelliM2005Physiologic evaluation of different levels of assistance during noninvasive ventilation delivered through a helmetChest12829849016236976
  • DiazGGAlcarazACTalaveraJCP2005Noninvasive positive-pressure ventilation to treat hypercapnic coma secondary to respiratory failureChest1279526015764781
  • DohertyMGreenstoneM1998Survey of non-invasive ventilation (NIPPV) in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) in the UKThorax53863610193373
  • DonaldsonGCWedzichaJA2006COPD exacerbations – 1: EpidemiologyThorax61164816443707
  • ElliottMW2002Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: a new gold standard?Intensive Care Med281691412580151
  • ElliottMW2004Non-invasive ventilation for acute respiratory diseaseBrit Med Bull72839715802610
  • EvansTW2001International Consensus Conference in Intensive Care Medicine: non-invasive positive pressure ventilation in acute respiratory failureAm J Respir Crit Care Med1632839111208659
  • FerrerMEsquinasAArancibiaF2003Noninvasive ventilation during persisting weaning failureAm J Respir Crit Care Med16870612689847
  • FerrerMValenciaMNicolasJM2006Early noninvasive ventilation averts extubation failure in patients at risk. A randomized trialAm J Respir Crit Care Med1731647016224108
  • GayPCHessDRHillNS2001Noninvasive proportional assist ventilation for acute respiratory insufficiency. A comparison with pressure support ventilationAm J Respir Crit Care Med16416061111719297
  • GiraultCDaudenthunIChevronV1999Noninvasive ventilation as a systematic extubation and weaning technique in acute-on-chronic respiratory failureAm J Respir Crit Care Med160869210390384
  • GiraultCBrielAHellotM-F2003Noninvasive mechanical ventilation in clinical practice: A 2-year experience in a medical intensive care unitCrit Care Med31552912576965
  • GirouESchortgenFDelclauxC2000Association of noninvasive ventilation with nosocomial infections and survival in critically ill patientsJAMA2842361711066187
  • HessDR2006Heliox and noninvasive positive-pressure ventilation: A role for heliox in exacerbations of chronic obstructive pulmonary disease?Respir Care516405016723041
  • HonrubiaTLopezFJGFrancoN2005Noninvasive vs. conventional mechanical ventilation in acute respiratory failure. A multicenter, randomized controlled trialChest12839162416354864
  • HuiDSHallSDChanMTV2006Noninvasive positive-pressure ventilation. An experimental model to assess air and particle dispersionChest1307304016963670
  • JaberSFodilRCarlucciA2000Noninvasive ventilation with Helium-Oxygen in acute exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med161119120010764311
  • JollietPAbajoBPasquinaP2001Non-invasive pressure support ventilation in severe community acquired pneumoniaIntensive Care Med278122111430536
  • JollietPTassauxDRoeselerJ2003Helium-oxygen versus air-oxygen noninvasive pressure support in decompensated chronic obstructive diseases : A prospective multicenter studyCrit Care Med8788412627000
  • KeenanSPGregorJSibbaldWJ2000Noninvasive positive pressure ventilation in the setting of severe, acute exacerbation of chronic obstructive pulmonary disease: more effective and less expensiveCrit Care Med28209410210890671
  • KeenanSPPowersCEMcCormackDG2005Noninvasive positive-pressure ventilation in patients with milder chronic obstructive pulmonary disease exacerbations: a randomized controlled trialRespir Care50610615871754
  • KramerNMeyerTJMehargJ1995Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failureAm J Respir Crit Care Med15117998067767523
  • KwokHMcCormackJCeceR2003Controlled trial of oronals versus nasal mask ventilation in the treatment of acute respiratory failureCrit Care Med3146847312576953
  • LelloucheFMaggioreSMDeyeN2002Effect of the humidification device on the work of breathing during noninvasive ventilationIntensive Care Med281582912415444
  • LieschingTKwokHHillNS2003Acute applications of noninvasive positive pressure ventilationChest12469971312907562
  • LightlowerJVWedzichaJAElliottMW2003Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbation of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysisBMJ3261859012543832
  • MassipJBetheseAJPaezJ2000Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trialLancet356263210892761
  • MeduriGUConoscentiCCMenasheP1989Noninvasive face mask ventilation in patients with acute respiratory failureChest95865702924616
  • MeduriGUTurnerREAbou-ShalaN1996Noninvasive positive pressure ventilation via face mask. First-line intervention in patients with acute hypercapnic and hypoxemic respiratory failureChest1091791938549183
  • MehtaSHillNS2001Noninvasive ventilationAm J Respir Crit Care Med1635407711179136
  • MiyoshiEFujinoYUchiyamaA2005Effects of gas leak on triggering function, humidification, and inspiratory oxygen fraction during noninvasive positive airway pressure ventilationChest1283691816304335
  • MoererOFischerSHarteltM2006Influence of two different interfaces for noninvasive ventilation compared to invasive ventilation on the mechanical properties and performance of a respiratory systemChest12914243116778258
  • NavaSAmbrosinoNBruschiC1997Physiological effects of flow and pressure triggering during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary diseaseThorax52249549093341
  • NavaSAmbrosinoNCliniE1998Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary diseaseAnn Intern Med12872189556465
  • NavaSEvangelistiIRampullaC1997Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failureChest111163189187186
  • NavaSCarboneGDiBattistaN2003Noninvasive ventilation in cardiogenic pulmonary edema. A multicenter, randomized trialAm J Respir Crit Care Med1681612826590
  • NavaSCerianaP2004Causes of failure of non-invasive mechanical ventilationRespir Care4929530314982651
  • NavaSNavalesiPContiG2006Time of non-invasive ventilationIntensive Care Med323617016477416
  • O’DonnellDEParkerCM2006COPD exacerbations – 3: PathophysiologyThorax613546116565268
  • PatilSPKrishnanJALechtzinN2003In-hospital mortality following acute exacerbations of chronic obstructive pulmonary diseaseArch Intern Med1631180612767954
  • PhuaJKongKLeeKH2005Noninvasive ventilation in hypercapnic acute respiratory failure due to chronic obstructive pulmonary disease vs. other conditions: effectiveness and predictors of failureIntensive Care Med31533915742175
  • PingletonS1994Complications associated with mechanical ventilation In Tobin MJ ed Principles and practice of mechanical ventilationNew YorkMcGraw-Hill77592
  • PlantPKOwenJLElliottMW2000aEarly use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomized controlled trialLancet35519315
  • PlantPKOwenJLElliottMW2000bOne year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administrationThorax555504
  • PlantPKOwenJLElliottMW2001Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcomeThorax567081211514692
  • PlantPKElliottMW2003Chronic obstructive pulmonary disease – 9: Management of ventilatory failure in COPDThorax585374212775872
  • PlantPKOwenJLParrottS2003Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomized controlled trialBMJ3269566112727767
  • RaccaFAppendiniLGregorettiC2005Effectiveness of mask and helmet interfaces to deliver noninvasive ventilation in a humn model of resistive breathingJ Appl Physiol9912627115961605
  • RelloJRodriguezATorresA2006Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumoniaEur Respir J2712101616510452
  • RichardJCCarlucciABretonL2002Bench testing of pressure support ventilation with three different generations of ventilatorsIntensive Care Med2810495712185424
  • Rodrìguez-RoisinR2006COPD exacerbations – 5: ManagementThorax615354416738044
  • RossiAPoleseGBrandiG1995Intrinsic positive end-expiratory pressure (PEEPi)Intensive Care Med21522367560497
  • ScalaRNaldiMArchinucciI2005Noninvasive positive pressure ventilation in patients with acute exacerbations of COPD and varying levels of consciousnessChest12816576616162772
  • SeneffMGWagnerDPWagnerRP1995Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary diseaseJAMA274185277500534
  • SimilowskiTMilic-EmiliJDerenneJP1996Respiratory mechanics during acute respiratory failure of chronic obstructive pulmonary diseaseDerenneJPWhitelawWASimilowskiTAcute respiratory failure in chronic obstructive pulmonary diseaseNew YorkMarcel Dekker2346
  • SquadroneEFrigerioPFogliatiC2004Noninvasive vs. invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistanceIntensive Care Med3013031015197438
  • TassauxDStrasserSFonsecaS2002Comparative bench study of triggering, pressurisation, and cycling between the home ventilator VPAP II and three ICU ventilatorsIntensive Care Med2812546112209273
  • VitaccaMRubiniFFoglioK1993Non-Invasive modalities of positive pressure ventilation improve the outcome of acute exacerbations in COLD patientsIntensive Care Med1945058294627
  • VitaccaMCliniEPaganiM2000Physiologic effects of early administered mask PAV (Proportional Assist Ventilation) in patients with chronic obstructive pulmonary disease and acute respiratory failureCrit Care Med281791610890621
  • VitaccaMAmbrosinoNCliniE2001Physiological response to pressure support ventilation delivered before and after extubation in COPD patients not capable of totally spontaneous autonomous breathingAm J Respir Crit Care Med1646384111520729

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.